Le point sur la prévention des ulcères hémorragiques en 2023.

Peptic ulcer disease is a known complication in patients receiving non-steroidal anti-inflammatory drugs, in intensive care units or on anticoagulation. Screening and treatment for Helicobacter pylori should be offered to patients starting NSAID therapy. Proton pump inhibitors should be given to patients at high risk of developing a bleeding ulcer and dying from this complication. [ABSTRACT FROM AUTHOR]